0001062993-23-013664.txt : 20230615
0001062993-23-013664.hdr.sgml : 20230615
20230615162856
ACCESSION NUMBER: 0001062993-23-013664
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butler John P.
CENTRAL INDEX KEY: 0001591467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37526
FILM NUMBER: 231017744
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001621443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260389433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
BUSINESS PHONE: 484-581-7505
MAIL ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
FORMER COMPANY:
FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc.
DATE OF NAME CHANGE: 20141003
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-06-13
0001621443
Zynerba Pharmaceuticals, Inc.
ZYNE
0001591467
Butler John P.
C/O ZYNERBA PHARMACEUTICALS, INC.
80 W. LANCASTER AVE., SUITE 300
DEVON
PA
19333
1
0
0
0
0
Common Stock
2023-06-13
4
A
0
47824
0
A
80880
D
Common Stock
2023-06-14
4
S
0
115
0.3481
D
80765
D
Stock Option (right to buy)
0.3501
2023-06-13
4
A
0
71736
0
A
2033-06-13
Common Stock
71736
71736
D
The restricted stock award vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders.
This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees and taxes in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.
The option vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders.
/s/ Albert P. Parker, Attorney-in-Fact
2023-06-15